Once-a-day Immunosuppression(CISECON_a_day)

NCT01964014 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Chronic Renal Disease

Interventions

DRUG: advagrf

Sponsor

Ajou University School of Medicine